← The Wire
STOKNasdaq
Stoke Therapeutics, Inc.
Pharmaceutical Preparations · DE · CIK 1623526
Restores protein expression with RNA medicine to treat genetic diseases
red 8-K · 90d
$1.86B
Market cap
$32.39
Last close
+1.2%
1D
+4.6%
5D
652K
Volume
Price · last 39 sessions-5.2%
May 4L $28.48 · H $34.18Jun 29
148
Total filings
Jun 4, 2026
Last filing
12/31
Fiscal year end
Insider Activity
In the 90 days to Mar 20, 2026: 7 sold $3.1M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 20, 2026 | Allan JonathanGENERAL COUNSEL & CORP SEC | Sell | 8,692 | $33.64 | $292K |
| Mar 20, 2026 | Allan JonathanGENERAL COUNSEL & CORP SEC | Sell | 601 | $34.41 | $21K |
| Mar 19, 2026 | Ticho BarryCHIEF MEDICAL OFFICER | Sell | 1,461 | $29.99 | $44K |
| Mar 18, 2026 | Ticho BarryCHIEF MEDICAL OFFICER | Sell | 6,100 | $31.28 | $191K |
| Mar 18, 2026 | Allan JonathanGENERAL COUNSEL & CORP SEC | Sell | 4,222 | $31.28 | $132K |
| Mar 18, 2026 | Leggett ThomasChief Financial Officer | Sell | 2,173 | $31.28 | $68K |
| Mar 18, 2026 | Hoitt JasonChief Patient Officer | Sell | 1,762 | $31.28 | $55K |
| Mar 18, 2026 | Ticho BarryCHIEF MEDICAL OFFICER | Sell | 483 | $31.79 | $15K |
| Mar 18, 2026 | Allan JonathanGENERAL COUNSEL & CORP SEC | Sell | 334 | $31.79 | $11K |
| Mar 18, 2026 | Leggett ThomasChief Financial Officer | Sell | 172 | $31.79 | $5K |
| Mar 18, 2026 | Hoitt JasonChief Patient Officer | Sell | 139 | $31.79 | $4K |
| Mar 18, 2026 | Ticho BarryCHIEF MEDICAL OFFICER | Sell | 103 | $32.85 | $3K |
| Mar 18, 2026 | Allan JonathanGENERAL COUNSEL & CORP SEC | Sell | 72 | $32.85 | $2K |
| Mar 18, 2026 | Leggett ThomasChief Financial Officer | Sell | 37 | $32.85 | $1K |
| Mar 18, 2026 | Hoitt JasonChief Patient Officer | Sell | 30 | $32.85 | $986 |
| Mar 17, 2026 | Ticho BarryCHIEF MEDICAL OFFICER | Sell | 3,577 | $32.74 | $117K |
| Mar 17, 2026 | Ticho BarryCHIEF MEDICAL OFFICER | Sell | 2,587 | $33.38 | $86K |
| Mar 17, 2026 | Allan JonathanGENERAL COUNSEL & CORP SEC | Sell | 2,476 | $32.74 | $81K |
| Mar 17, 2026 | Allan JonathanGENERAL COUNSEL & CORP SEC | Sell | 1,791 | $33.38 | $60K |
| Mar 17, 2026 | Leggett ThomasChief Financial Officer | Sell | 1,274 | $32.74 | $42K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance